New Zealand Gazette – 1999 – No. 23

Page 564

✨ Medicines Notices

564 NEW ZEALAND GAZETTE No. 23

Dated this 16th day of February 1999.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

g01353

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Name and Strength	Form	Name and Address of Manufacturer	Proprietary Name (if any)
Mycophenolate mofetil 250 mg	Capsule	Syntex Puerto Rico Inc., Humacao, Puerto Rico and Roche Products Limited, Welwyn Garden City, Hertfordshire, United Kingdom	CellCept
Mycophenolate mofetil 500 mg	Tablet	Syntex Puerto Rico Inc., Humacao, Puerto Rico and Roche Products Limited, Welwyn Garden City, Hertfordshire, United Kingdom	CellCept
Terbinafine hydrochloride 10 mg/g	Solution, topical	Novartis Pharma AG., Basel, Switzerland	Lamisil
Terbinafine hydrochloride 10 mg/g	Spray, topical	Novartis Pharma AG., Basel, Switzerland	Lamisil
Pravastatin sodium 5 mg, 10 mg, 20 mg	Tablets	Bristol-Myers Squibb Pharmaceuticals Pty Limited, Noble Park, Victoria, Australia	Lipostat
Pravastatin sodium 10 mg, 20 mg, 40 mg	Tablets (reduced mass formulation)	Bristol-Myers Squibb Pharmaceuticals Pty Limited, Noble Park, Victoria, Australia	Lipostat
Ropivacaine hydrochloride monohydrate 2 mg/mL	Infusion, solution	Astra Pharmaceuticals Pty Limited, North Ryde, New South Wales, Australia and NPBI BV., Emmer-Compascuum, The Netherlands	Naropin
Varicella vaccine 2,000PFU in 0.5 mL	Injection, solution	SmithKline Beecham Biologicals Manufacturing, Rixensart, Belgium	Varilrix
Simvastatin 5 mg, 10 mg, 20 mg, 40 mg	Tablets, film coated	Merck Sharp & Dohme Limited, Cramlington, Northumberland, England; Merck Sharp & Dohme (Aust) Pty Limited, South Granville, New South Wales, Australia and Merck & Co Inc., West Point, Pennsylvania, United States of America	Zocor
Simvastatin 80 mg	Tablet, film coated	Merck Sharp & Dohme Limited, Cramlington, Northumberland, England	Zocor

Dated this 20th day of February 1999.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

g01479

Classification of Medicines

Pursuant to section 106 (1) of the Medicines Act 1981, I, G. R. Boyd, Chief Advisor, Regulation and Safety, acting under delegated authority, hereby declare the following:

The medicines listed in Schedule 1 to this notice are classified as prescription medicines.
The medicines listed in Schedule 2 to this notice are classified as restricted medicines.
The medicines listed in Schedule 3 to this notice are classified as pharmacy-only medicines.

Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.

Unless specific reference is made otherwise, every reference applies also to medicines that are:

(a) Preparations and admixtures containing any proportion of any substance listed in the notice;

(b) Salts and esters of any substance listed in the notice;

(d) Salts or oxides of elements listed in the notice.

Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using the free acid, base, alcohol or element unless specifically stated otherwise.

Schedule 1

Prescription Medicines

astemizole

basiliximab

cerivastatin

daclizumab

desonide

diphenhydramine; in medicines for insomnia or anxiety unless specified elsewhere in this Schedule

doxylamine; in medicines for insomnia or anxiety unless specified elsewhere in this Schedule

fluvoxamine

grepafloxacin

PDF embedding disabled (Crown copyright)

View this page online at:

VUW Te Waharoa — NZ Gazette 1999, No 23

NZLII — NZ Gazette 1999, No 23

The Executive Wing of Parliament (depicted) is universally known as The Beehive. It was completed in 1977 and remains the primary office for the elected Government of the day.

✨ LLM interpretation of page content

🏥 Consent to the Distribution of Changed Medicines

Domain🏥 Health & Social Welfare
Dated16 February 1999
KeywordsMedicines Act, Distribution, Changed Medicines, Consent
👩‍💼 Officials

G. R. Boyd, Chief Advisor, Regulation and Safety

🏥 Classification of Medicines

Domain🏥 Health & Social Welfare
Dated20 February 1999
KeywordsMedicines Act, Classification, Prescription Medicines, Restricted Medicines, Pharmacy-only Medicines
👩‍💼 Officials

G. R. Boyd, Chief Advisor, Regulation and Safety

As the Gazette has been published for more than 185 years, copyright status depends on the publication date of each issue:

1840–1925 (Public Domain): Issues of the New Zealand Gazette and Provincial Gazettes from this period are in the public domain, as the term of Crown copyright (100 years) has expired. Mechanical reproductions (e.g., scanned PDFs) of these public domain documents do not attract new copyright.
1926–1999 (Crown Copyright): Issues from this period remain subject to Crown copyright. Usage of these issues in this project is "Fair Dealing" for research purposes and consistent with the spirit of the open-access principles championed by NZGOAL, ie, "The default licensing position under ... NZGOAL is the Creative Commons Attribution 4.0 International licence ... [t]o the greatest extent possible, agencies should apply this licence to copyright material on their websites"
2000–Present (CC-BY 3.0 NZ): Gazette issues published on gazette.govt.nz are Crown copyright but are explicitly licensed by the Department of Internal Affairs under the Creative Commons Attribution 3.0 New Zealand licence (CC-BY 3.0 NZ). This project redistributes this content in accordance with those terms.

Nothing in this project is intended to infringe copyright, trademark law or personal privacy. Please contact me immediately if you have any concerns.

Third-Party Content

Where third-party content (e.g., notices submitted by external organisations) is identified within the Gazette, users should satisfy themselves regarding the copyright status of that specific content, as it may be subject to different ownership terms than the Gazette itself.

Sources and Attribution

NZ Gazette Sources

The primary sources for the issues of the NZ Gazette indexed by this project are:

New Zealand Gazette Archive, provided by Victoria University Library, copyright 2008 LexisNexis NZ Limited, Crown Copyright of New Zealand Gazette Office
- Issues from 1841-2008, including the New Munster, New Ulster, and Provincial Gazettes
New Zealand Gazettes by New Zealand Legal Information Institute (note: "NZLII is not the copyright owner in the source documents published on NZLII")
- Issues from 1913-1999
Gazette.govt.nz, Crown copyright / licensed by the Department of Internal Affairs under CC-BY 3.0 NZ
- Issues from 2000-2017

Additional Sources

Wellington City Recollect have made available a comprehensive and excellent-quality scan of the Wellington Provincial Gazette which was used to fill in a number of issues missing from Victoria University's Gazette Archive; in particular, all 1856 issues, issues 22-34 for 1864 and issues 9-19 for 1870.
27 issues of The New Zealand Advertiser and Bay of Islands Gazette (1840) were sourced from Papers Past (public domain).
Gazette Extraordinary No. 1 (1840), held at the Alexander Turnbull Library, Wellington, New Zealand. Imaged by Luke Howison at the National Library reading rooms; PDF released into the public domain.

PDF Icon

The PDF PDF Icon was made by Good Ware, CC BY-SA 4.0.

Masthead

The logo in the header is an edited version of “Winning Coat of Arms Competition Entry, 1908” by Archives New Zealand, CC BY 2.0 (found via Wikipedia).

Who made this?

I'm Luke Howison, a freelance web developer with an interest in genealogy. I have created several websites for genealogical research, such as NZ Ancestor Search Helper.